2616 — CStone Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.87bn
- HK$3.54bn
- CNY407.21m
Annual cashflow statement for CStone Pharmaceuticals, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -1,221 | -1,920 | -903 | -367 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 512 | 349 | 173 | -141 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 186 | 64.5 | 72.6 | -139 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -508 | -1,484 | -612 | -589 | — |
| Capital Expenditures | -71.4 | -149 | -102 | -65 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,252 | -677 | 467 | 685 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1,181 | -827 | 365 | 620 | — |
| Financing Cash Flow Items | -1.32 | -2.24 | -11.8 | -13.5 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,389 | 92.3 | 28.5 | 388 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,898 | -2,282 | -184 | 438 | — |